文献速递美容整形创面修复

面部透明质酸注射史患者迟发性眶周水肿:诊断与治疗综述

Late-onset periorbital edema in patients with a history of facial hyaluronic acid injection: A review on diagnosis and management.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2024-09-20

本文综述面部透明质酸注射后迟发性眶周水肿的临床表现、机制、危险因素、诊断与处理。迟发可在数周至数年后出现,表现为眼睑与颧部弥漫性水肿,可被感染等触发因素加重。病理生理区分炎症性与非炎症性,强调淋巴与静脉回流障碍;超声有助于制定治疗计划,治疗可包括皮质类固醇、透明质酸酶降解及射频微针等后续美容操作。

要点

  • 迟发性眶周水肿可在透明质酸注射后数周至数年后出现,表现为眼睑与颧部弥漫性水肿。
  • 病理生理区分炎症性与非炎症性原因,强调淋巴与静脉回流障碍。
  • 超声辅助评估有助于治疗计划,治疗可包括皮质类固醇、透明质酸酶及射频微针等。

核心结论

  • 面部透明质酸注射后迟发性眶周水肿以往罕见,现已常见,认识和处治该并发症对优化患者诊疗与结局至关重要。
  • 治疗通常包括调整透明质酸酶剂量以去除透明质酸,眼睑成形术、射频微针或填充剂再注射等附加操作可能改善治疗后外观。

研究设计与样本

  • 文献综述:检索描述透明质酸注射后颧部水肿与眼睑水肿的文章,对资料进行分类与并列比较。

主要发现

  • 透明质酸注射后眶周水肿发生率不一,迟发可在数周至数年后出现。
  • 表现为眼睑与颧部弥漫性水肿,有时可被感染等触发因素加重。
  • 病理生理讨论区分炎症性与非炎症性原因,强调淋巴与静脉回流障碍。
  • 危险因素包括填充剂特性、注射深度与患者易感性。
  • 使用超声进行恰当的患者评估有助于治疗计划,治疗可涉及皮质类固醇、透明质酸酶去除透明质酸及射频微针等后续美容操作。

临床怎么用

  • 使用超声进行恰当的患者评估有助于治疗计划。
  • 治疗可涉及皮质类固醇、透明质酸酶去除透明质酸及射频微针等后续美容操作。
  • 需行下眼睑成形术的病例,应考虑在透明质酸溶解后行手术干预。
  • 治疗通常包括调整透明质酸酶剂量以去除透明质酸;眼睑成形术、射频微针或填充剂再注射等附加操作可能改善治疗后外观。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hyaluronic acid (HA) injections for soft tissue augmentation, particularly in the facial area, have become increasingly popular. Nevertheless, a growing number of reports indicate complications associated with this procedure, posing challenges for practitioners. One commonly encountered complication is periorbital edema. OBJECTIVE: To review the existing literature on late-onset periorbital edema following HA injections, focusing on clinical presentation, proposed mechanisms, risk factors, diagnostics, and management strategies. METHODS: A literature search was conducted to find articles describing findings on malar edema and eyelid edema following HA injections. The gathered data were categorized and juxtaposed to provide a clearer understanding of this phenomenon. RESULTS: Incidence rates of periorbital edema post-HA injection vary, with delayed onset occurring weeks to years later. The manifestation involves diffuse edema in the eyelids and malar area, sometimes worsened by trigger factors like infections. Pathophysiology discussions distinguish between inflammatory and non-inflammatory causes, highlighting lymphatic and venous flow disturbances. Risk factors include filler characteristics, injection depth, and patient predispositions. Proper patient evaluation using ultrasonography aids in treatment planning, which could involve corticosteroids, hyaluronidase for HA removal, and subsequent cosmetic procedures like radiofrequency (RF) microneedling. Surgical interventions should be considered after HA dissolution, especially in cases requiring lower blepharoplasty. CONCLUSION: Late periorbital edema post-facial HA injections, once rare, is now frequently seen. Understanding and addressing this complication is essential for optimizing patient care and outcomes in clinical practice. Treatment typically involves adjusting hyaluronidase dosage for HA removal. Additional procedures like blepharoplasty, RF needling, or filler reinjection may enhance post-treatment appearance.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Eshraghi B, Babaei L, Aghajani M, et al. Late-onset periorbital edema in patients with a history of facial hyaluronic acid injection: A review on diagnosis and management. J Plast Reconstr Aesthet Surg. 2024. PMID: 39395232. doi:10.1016/j.bjps.2024.09.061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。